KBA-CARDIOLOGY LTD
KBA-CARDIOLOGY LTD
Company Registration No. 08945300 (England and Wales)
Page
- 2 -
2022
2021
Notes
£
£
Fixed assets
Current assets
Cash at bank and in hand
Net current assets/(liabilities)
(1,561 )
Net assets
Capital and reserves
Called up share capital
Profit and loss account
Shareholders' funds
The financial statements were approved by the Board and authorised for issue on 27 April 2022 and were signed on its behalf by
- 3 -
1
Statutory information
2
Compliance with accounting standards
3
Accounting policies
These financial statements for the year ended 31 March 2022 are the first financial statements that comply with FRS 102 Section 1A Small Entities. The date of transition is 1 April 2020.
The transition to FRS 102 Section 1A Small Entities has resulted in a small number of changes in accounting policies to those used previously.
The nature of these changes and their impact on opening equity and profit for the comparative period are explained in the notes below.
Basis of preparation
Presentation currency
Tangible fixed assets and depreciation
Computer equipment
4
Tangible fixed assets
Computer equipment
£
Cost or valuation
At cost
At 1 April 2021
Additions
At 31 March 2022
Depreciation
At 1 April 2021
Charge for the year
At 31 March 2022
Net book value
At 31 March 2022
At 31 March 2021
- 4 -
5
Creditors: amounts falling due within one year
2022
2021
£
£
Taxes and social security
Other creditors
Loans from directors
Accruals
6
Average number of employees
During the year the average number of employees was 1 (2021: 0 ).
- 5 -